Therapeutic Use of Botulinum Toxin in Neurorehabilitation
Author Information
Author(s): Domenico Intiso
Primary Institution: Scientific Institute, Hospital IRCSS “Casa Sollievo della Sofferenza”
Hypothesis
The study investigates the efficacy of botulinum toxins (BTX) in treating various neurological disorders requiring neuro-rehabilitation.
Conclusion
Botulinum toxins are effective in reducing spasticity and improving quality of life in patients with neurological disorders, although their impact on functional outcomes remains controversial.
Supporting Evidence
- Botulinum toxins have been shown to reduce spasticity in various neurological conditions.
- BTX-A is considered the first line of treatment for focal spasticity.
- Adverse events from BTX treatment are generally mild and transient.
Takeaway
Botulinum toxin can help relax tight muscles in people with certain brain injuries, making it easier for them to move and feel better.
Methodology
The review discusses the applications of botulinum toxins in treating spasticity and other neurological disorders, summarizing existing literature and clinical practices.
Limitations
The effectiveness of BTX in improving functional outcomes is not consistently supported by evidence, and further studies are needed to clarify its role in rehabilitation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website